NewsRoom Articles - Page 101 of 207

WednesdayJul 06, 2022 1:58 pm

Brain Cell Regulation Mechanism Could Unlock Novel Treatment Modalities for Neurological Conditions

Neurological conditions such as Huntington's and Alzheimer’s disease as well as spinal cord injuries can be nigh impossible to treat. In most cases, all doctors and caregivers can do is reduce the severity of the symptoms and find ways to improve a patient’s quality of life. Consequently, scientists are always looking for more effective treatments for the millions of people in the world who live with neurological disorders. Researchers studying the brain and how it responds to disease and injury have now mapped a brain cell regulation mechanism that could allow them to develop novel treatments for brain disorders and…

WednesdayJul 06, 2022 11:15 am

Odyssey Health, Inc. (ODYY) Optimistic About Drug/Tech IP as Industry Studies Big Pharma M&A Outlook

Biopharma industry analysts have been expecting 2022 to be a heady year for big-pharma acquisitions or partnerships with promising medical upstarts following a time period that has left the biggest companies flush with cash Among promising device and drug developers, Odyssey Health Inc. has been working on novel solutions to brain concussion injuries, a rare neurodegenerative disease, obstructive choking incidents and early-stage coronary artery disease (“CAD”) detection Odyssey Health Inc. is taking its brain concussion solution to a Phase 1 clinical human trial currently with possible progression to Phase 2 before the end of the year The company likewise anticipates…

TuesdayJul 05, 2022 1:55 pm

New Study Finds That Probiotics May Be Useful in Fight Against Depression

Gut biome, or the community of bacteria that live in the digestive tract, plays a significant role in overall health. If the balance of healthy and unhealthy bacteria in the stomach and intestines gets out of balance, individuals are likely to develop a variety of issues, including high blood sugar, weight gain and high cholesterol. According to a study that was recently published in the “Translation Psychiatry” journal, there may be a link between gut bacteria and mental health. The study found that probiotics, which consist of “good bacteria” that can benefit the digestive system, can be used to alleviate…

FridayJul 01, 2022 10:43 am

Exploring Why Women Have Heightened Risk of Developing Long COVID Infections

As the coronavirus pandemic raged on and millions of people across the world became infected with the virus, it became clear that for some people, the symptoms of COVID did not abate after a few weeks. Rather, these individuals experienced a variety of symptoms for months after their initial diagnosis, a phenomenon that was soon dubbed long COVID. Additionally, it seemed like women had a heightened risk of experiencing long COVID than men. This is despite the fact that previous research had shown men’s immune systems to be weaker against the coronavirus compared to women. Researchers looking into the prevalence…

FridayJul 01, 2022 9:00 am

Odyssey Health, Inc. (ODYY) Reports Positive Findings on Phase 1 Clinical Trials of PRV-002 for Concussions

No adverse reactions were reported in any of the healthy subjects enrolled in the Cohort II Phase 1 clinical trial of PRV-002 Company in talks with military training sites for Phase 2 and 3 clinical trials on concussed patients The CDC estimates that approximately 1.6 to 3.8 million sports and recreation-related concussions occur annually, for which there is no FDA-approved treatment The global concussion market size was valued at $6.8 billion in 2019. This value is expected to rise to $8.9 billion by 2027, growing at a CAGR of 3.6% Odyssey Health (OTC: ODYY), a medical company focused on unique,…

ThursdayJun 30, 2022 1:38 pm

Virtual Biopsies May Revolutionize Procedures Used in Heart Transplants

Heart transplant patients often undergo cardiac biopsies in the weeks and months after the transplant to check for heart problems and rejection. The procedure, which involves taking a small sample of heart tissue for testing, can be quite invasive. However, thanks to a new technique developed by researchers from St. Vincent’s Hospital Sydney and Victor Chang Cardiac Research Institute, heart transplant survivors won’t have to deal with invasive cardiac biopsies anymore. Scientists have developed a new magnetic resonance imaging (MRI) technique that can allow clinicians to check for signs of heart transplant rejection without hospital admissions and with minimal complications.…

WednesdayJun 29, 2022 12:44 pm

AI May Help Improve Brain Cancer Diagnosis

Traditionally, brain tumors are diagnosed by computer topography scans (CT), magnetic resonance imaging (MRI) or a neurologic exam. However, researchers from the Karl Landsteiner University for Health Sciences (KL Krems) have now discovered a more precise and accurate way of diagnosing brain cancer by using artificial intelligence (AI) combined with physiological imaging. The researchers used several multiclass machine learning techniques to study data sourced from MRIs and classified different brain tumors. They then compared the results produced through machine learning with classifications that were made by human specialists. Although the experts were better at specificity and sensitivity, the researchers discovered…

WednesdayJun 29, 2022 10:30 am

Odyssey Health, Inc. (ODYY) Taps Military Advisors to Address Target Market for PRV-002 Concussion Drug

Odyssey Health is a medical company focused on developing medical products for conditions with unmet needs, one of which is concussion Currently, concussions do not have an FDA-approved treatment Soldiers form a significant population of people who frequently experience multiple concussions throughout their career Concussion has only recently received greater attention as different parties seek to understand the condition and possible treatments Odyssey is at the forefront of this pursuit for treatment and has developed the PRV-002 drug candidate that it intends to use on the military as part of a Phase II clinical trial The company announced the formation…

TuesdayJun 28, 2022 1:36 pm

New Report Says Smoking Amplifies Schizophrenia and Depression Risk

New research has found that smoking can increase an individual's risk of developing depression and schizophrenia. According to a report from the University of Bristol, the risk of developing depression goes up by an estimated 53% to 130% while the risk of developing schizophrenia increases by roughly 52% to 127% when you smoke regularly. The research was shared at the Royal College of Psychiatrists International Congress and will be used to inform the United Kingdom government’s new Tobacco Control Plan. Researchers will also provide the Parliament of the UK with data on the number of smokers in the country who…

TuesdayJun 28, 2022 11:15 am

Aditxt Inc. (NASDAQ: ADTX) Authorizes New Channel Partner to Offer AditxtScore(TM) Amid Rising COVID-19 Cases and Possible Fall/Winter Waves

Aditxt, Inc. is a is a biotech innovation company developing and commercializing technologies focused on monitoring and reprogramming the immune system. The Company’s product AditxtScore(TM) is a proprietary immune mapping technology designed to provide a personalized profile of the immune system; AditxtScore(TM) for COVID-19 is the Aditxt’s first commercial product Aditxt recently announced it had authorized a new channel partner – Premier Medical Laboratory Services (“PMLS”), a leading advanced medical diagnostics lab –to offer AditxtScore(TM) This announcement comes amid reports warning of a fall and winter COVID-19 wave occasioned by waning immunity or a possible “nasty new variant” Already, the…